IL-2/IL-2R pathway in dendritic cell modulates both their cytokine synthesis profiles and their capacity to activate allogeneic CD4+ T lymphocytes;La voie IL-2/IL-2R chez la cellule dendritique module à la foisleur synthèse de cytokines et leur capacité à activerdes lymphocytes T CD4+ allogéniques

Pathologie Biologie

Volumn 59, Issue 3, 2011, Pages

  Mnasria, K ^a,b   Lagaraine, C ^c   Manaa, J ^b   Lebranchu, Y ^c,d   Oueslati, R ^a  

^a Struggle and Prevention   (Tunisia)

^b MILITARY HOSPITAL OF TUNIS   (Tunisia)

^c UNIVERSITÉ DE TOURS   (France)

^d UFR des sciences pharmaceutiques   (France)

Author keywords

Dendritic cells; IL 2 receptor (CD25); Interleukin 2

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ARTICLE; AUTOCRINE EFFECT; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIBODIES, MONOCLONAL; AUTOCRINE COMMUNICATION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MONOCYTES; SIGNAL TRANSDUCTION;

EID: 79958708803     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.03.002     Document Type: Article

References (29)

1. Heath W.R., Villadangos J.A. The definition of the physiological functions of dendritic cells is undergoing refinement, as specialization of dendritic cell labor depends on their previous encounters. Nat Immunol 2005, 6:125-128.
2. Rescigno M. Dendritic cells and the complexity of microbial infection. Trends Microbiol 2002, 10:425-431.
3. Lagaraine C., Hoarau C., Chabot V., Velge-Roussel F., Lebranchu Y. Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways. Int Immunol 2005, 17:351-363.
4. Fukao T., Koyasu S. Expresion of functional IL-2 receptors on mature splenic dendritic cells. Eur. J. Immunol 2000, 30:1453-1457.
5. Adorini L., Giarratana N., Penna G. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Seminar Immunol 2004, 16:127-134.
6. Reis e Sousa C. Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol 2004, 16:21-25.
7. Foti M., Granucci F., Castagnoli P.R. A central role for tissue - resident dendritic cells in innate responses. Trends in Immunol 2004, 25:650-654.
8. Nelson B.H. IL-2 Regulatory T Cells and Tolerance. Immunology 2004, 172:3983-3988.
9. Vincenti F., Kirkman R., Light S., et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 1998, 338:161-165.
10. Gibelli N.E.M., Pinho-Apezzato M.L., Miyatani H.T., Maksoud-Filho J.G., Silva M.M., et al. Basiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver transplantation: comparative study. Transplant Proc 2004, 36:956-957.
11. Sauma D., Fierro A., Mora J.R., Lennon-Duménil A.M., Bono M.R., et al. Cyclosporine preconditions dendritic cells during differentiation and reduces IL-2 and IL-12 production following activation: a potential tolerogenic effect. Transplant Proc 2003, 35:2515-2517.
12. Kronin D., Vremec D., Shortman K. Does the IL-2 receptor α chain induced on dendritic cells have a biological function?. Int Immunol 1998, 10:237-240.
13. Roifman M.C. Human IL-2 receptor α chain deficiency. Pediatr Res 2000, 48:6-11.
14. Granucci F., Vizzardelli C., Pavelka N., Feau S., Persico M., Virzi E., et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nature Immunol 2001, 2:882-888.
15. Fierro A., Mora J.R., Bono M.R., Morales J., Buckel E., et al. Dendritic cells and the mode of action of anticalcineurinic drugs: an integrating hypothesis. Nephrol. Dial. Transplant 2003, 18:467-469.
16. Fernandez N.C., Lozier A., Flament C. Dendritic cells directly trigger NK cell functions: crosstalk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999, 5:405-411.
17. Rossi M., Young J.W. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol. 2005, 175:1373-1381.
18. Münz C., Steinman R.M., Fujii S.I. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med. 2005, 202:203-207.
19. Granucci F., Feau S., Angeli V., Trottein F., Ricciardi-Castagnoli P. Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J Immunol. 2003, 170:5075-5081.
20. Bielekova B., Catalfamo M., Reichert-Scrivner S., et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA 2006, 103:5941-5946.
21. Yamazaki S., Inaba K., Tarbell K.V., Steinman R.M. Dendritic cells expand antigenspecific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 2006, 212:314-329.
22. Steinman R.M., Gutchinov B., Witmer M.D., Nussenzweig M.C. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J Exp Med. 1983, 157:613-627.
23. Grakoui A., et al. The immunological synapse: a molecular machine controlling T-cell activation. Science 1999, 2:221-225.
24. Park C.S., Park W.R., Sugimoto N., Nakahira M., Ahn H.J., Hamaoka T., et al. Differential effects of N-acetyl-l-cysteine on IL-2- vs IL-12-driven proliferation of a T cell clone: implications for distinct signalling pathways. Cytokine. 2000, 9:1419-1422.
25. Romano C.C., Mendes-Giannini M.J.S., Duarte A.J.S. Gil Benard: IL-12 and neutralization of endogenous IL-10 revert the in vitro antigen-specific cellular immunosuppression of paracoccidioidomycosis patients. Cytokine 2000, 3:149-157.
26. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002, 99:351-358.
27. Säemann M.D., Kelemen P., Böhmig G.A., Hörl W.H., Zlabinger G.J. Hyporesponsiveness in alloreactive Tcells by NFκB inhibitor treated dendritic cells: resistance to calcineurin inhibition. American Journal of Transplantation 2004, 4:1448-1458.
28. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
29. Granucci F., Vizzardelli C., Virzi E., Rescigno M., Ricciardi-Castagnoli P. Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur J Immunol 2001, 31:2539-2546.